22-28694093-A-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_007194.4(CHEK2):c.1400T>A(p.Leu467*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. L467L) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_007194.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- CHEK2-related cancer predispositionInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- Li-Fraumeni syndrome 2Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
- acute myeloid leukemiaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_007194.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CHEK2 | NM_007194.4 | MANE Select | c.1400T>A | p.Leu467* | stop_gained | Exon 13 of 15 | NP_009125.1 | ||
| CHEK2 | NM_001005735.3 | c.1529T>A | p.Leu510* | stop_gained | Exon 14 of 16 | NP_001005735.1 | |||
| CHEK2 | NM_001438293.1 | c.1493T>A | p.Leu498* | stop_gained | Exon 14 of 16 | NP_001425222.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CHEK2 | ENST00000404276.6 | TSL:1 MANE Select | c.1400T>A | p.Leu467* | stop_gained | Exon 13 of 15 | ENSP00000385747.1 | ||
| CHEK2 | ENST00000382580.6 | TSL:1 | c.1529T>A | p.Leu510* | stop_gained | Exon 14 of 16 | ENSP00000372023.2 | ||
| CHEK2 | ENST00000402731.6 | TSL:1 | c.1199T>A | p.Leu400* | stop_gained | Exon 11 of 13 | ENSP00000384835.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 6.93e-7 AC: 1AN: 1443546Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 718546 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial cancer of breast Pathogenic:2
This sequence change creates a premature translational stop signal (p.Leu467*) in the CHEK2 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with CHEK2-related conditions. Loss-of-function variants in CHEK2 are known to be pathogenic (PMID: 21876083, 24713400). For these reasons, this variant has been classified as Pathogenic.
This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation.
not provided Pathogenic:1
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.L467* pathogenic mutation (also known as c.1400T>A), located in coding exon 12 of the CHEK2 gene, results from a T to A substitution at nucleotide position 1400. This changes the amino acid from a leucine to a stop codon within coding exon 12. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at